This report aims to provide a comprehensive presentation of the global market for HIV Antiretroviral Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Antiretroviral Therapy. This report contains market size and forecasts of HIV Antiretroviral Therapy in global, including the following market information:
Global HIV Antiretroviral Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global HIV Antiretroviral Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Nucleoside Reverse Transcriptase Inhibitors (NRTI) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of HIV Antiretroviral Therapy include Gilead, Roche, ViiV Healthcare, Boehringer Ingelheim, Johnson and Johnson, Mylan, Bionor Pharma, Vertex Pharmaceuticals and Merck, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the HIV Antiretroviral Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV Antiretroviral Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global HIV Antiretroviral Therapy Market Segment Percentages, by Type, 2022 (%)
Nucleoside Reverse Transcriptase Inhibitors (NRTI)
Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Protease Inhibitor (PI)
Global HIV Antiretroviral Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global HIV Antiretroviral Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global HIV Antiretroviral Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global HIV Antiretroviral Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HIV Antiretroviral Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies HIV Antiretroviral Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead
Roche
ViiV Healthcare
Boehringer Ingelheim
Johnson and Johnson
Mylan
Bionor Pharma
Vertex Pharmaceuticals
Merck
CIPLA
AbbVie
Outline of Major Chapters:
Chapter 1: Introduces the definition of HIV Antiretroviral Therapy, market overview.
Chapter 2: Global HIV Antiretroviral Therapy market size in revenue.
Chapter 3: Detailed analysis of HIV Antiretroviral Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of HIV Antiretroviral Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 HIV Antiretroviral Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global HIV Antiretroviral Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global HIV Antiretroviral Therapy Overall Market Size
2.1 Global HIV Antiretroviral Therapy Market Size: 2022 VS 2029
2.2 Global HIV Antiretroviral Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top HIV Antiretroviral Therapy Players in Global Market
3.2 Top Global HIV Antiretroviral Therapy Companies Ranked by Revenue
3.3 Global HIV Antiretroviral Therapy Revenue by Companies
3.4 Top 3 and Top 5 HIV Antiretroviral Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies HIV Antiretroviral Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 HIV Antiretroviral Therapy Players in Global Market
3.6.1 List of Global Tier 1 HIV Antiretroviral Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 HIV Antiretroviral Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global HIV Antiretroviral Therapy Market Size Markets, 2022 & 2029
4.1.2 Nucleoside Reverse Transcriptase Inhibitors (NRTI)
4.1.3 Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
4.1.4 Protease Inhibitor (PI)
4.2 By Type - Global HIV Antiretroviral Therapy Revenue & Forecasts
4.2.1 By Type - Global HIV Antiretroviral Therapy Revenue, 2018-2023
4.2.2 By Type - Global HIV Antiretroviral Therapy Revenue, 2024-2029
4.2.3 By Type - Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global HIV Antiretroviral Therapy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global HIV Antiretroviral Therapy Revenue & Forecasts
5.2.1 By Application - Global HIV Antiretroviral Therapy Revenue, 2018-2023
5.2.2 By Application - Global HIV Antiretroviral Therapy Revenue, 2024-2029
5.2.3 By Application - Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global HIV Antiretroviral Therapy Market Size, 2022 & 2029
6.2 By Region - Global HIV Antiretroviral Therapy Revenue & Forecasts
6.2.1 By Region - Global HIV Antiretroviral Therapy Revenue, 2018-2023
6.2.2 By Region - Global HIV Antiretroviral Therapy Revenue, 2024-2029
6.2.3 By Region - Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America HIV Antiretroviral Therapy Revenue, 2018-2029
6.3.2 US HIV Antiretroviral Therapy Market Size, 2018-2029
6.3.3 Canada HIV Antiretroviral Therapy Market Size, 2018-2029
6.3.4 Mexico HIV Antiretroviral Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe HIV Antiretroviral Therapy Revenue, 2018-2029
6.4.2 Germany HIV Antiretroviral Therapy Market Size, 2018-2029
6.4.3 France HIV Antiretroviral Therapy Market Size, 2018-2029
6.4.4 U.K. HIV Antiretroviral Therapy Market Size, 2018-2029
6.4.5 Italy HIV Antiretroviral Therapy Market Size, 2018-2029
6.4.6 Russia HIV Antiretroviral Therapy Market Size, 2018-2029
6.4.7 Nordic Countries HIV Antiretroviral Therapy Market Size, 2018-2029
6.4.8 Benelux HIV Antiretroviral Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia HIV Antiretroviral Therapy Revenue, 2018-2029
6.5.2 China HIV Antiretroviral Therapy Market Size, 2018-2029
6.5.3 Japan HIV Antiretroviral Therapy Market Size, 2018-2029
6.5.4 South Korea HIV Antiretroviral Therapy Market Size, 2018-2029
6.5.5 Southeast Asia HIV Antiretroviral Therapy Market Size, 2018-2029
6.5.6 India HIV Antiretroviral Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America HIV Antiretroviral Therapy Revenue, 2018-2029
6.6.2 Brazil HIV Antiretroviral Therapy Market Size, 2018-2029
6.6.3 Argentina HIV Antiretroviral Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa HIV Antiretroviral Therapy Revenue, 2018-2029
6.7.2 Turkey HIV Antiretroviral Therapy Market Size, 2018-2029
6.7.3 Israel HIV Antiretroviral Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia HIV Antiretroviral Therapy Market Size, 2018-2029
6.7.5 UAE HIV Antiretroviral Therapy Market Size, 2018-2029
7 HIV Antiretroviral Therapy Companies Profiles
7.1 Gilead
7.1.1 Gilead Company Summary
7.1.2 Gilead Business Overview
7.1.3 Gilead HIV Antiretroviral Therapy Major Product Offerings
7.1.4 Gilead HIV Antiretroviral Therapy Revenue in Global Market (2018-2023)
7.1.5 Gilead Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche HIV Antiretroviral Therapy Major Product Offerings
7.2.4 Roche HIV Antiretroviral Therapy Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 ViiV Healthcare
7.3.1 ViiV Healthcare Company Summary
7.3.2 ViiV Healthcare Business Overview
7.3.3 ViiV Healthcare HIV Antiretroviral Therapy Major Product Offerings
7.3.4 ViiV Healthcare HIV Antiretroviral Therapy Revenue in Global Market (2018-2023)
7.3.5 ViiV Healthcare Key News & Latest Developments
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Company Summary
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim HIV Antiretroviral Therapy Major Product Offerings
7.4.4 Boehringer Ingelheim HIV Antiretroviral Therapy Revenue in Global Market (2018-2023)
7.4.5 Boehringer Ingelheim Key News & Latest Developments
7.5 Johnson and Johnson
7.5.1 Johnson and Johnson Company Summary
7.5.2 Johnson and Johnson Business Overview
7.5.3 Johnson and Johnson HIV Antiretroviral Therapy Major Product Offerings
7.5.4 Johnson and Johnson HIV Antiretroviral Therapy Revenue in Global Market (2018-2023)
7.5.5 Johnson and Johnson Key News & Latest Developments
7.6 Mylan
7.6.1 Mylan Company Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan HIV Antiretroviral Therapy Major Product Offerings
7.6.4 Mylan HIV Antiretroviral Therapy Revenue in Global Market (2018-2023)
7.6.5 Mylan Key News & Latest Developments
7.7 Bionor Pharma
7.7.1 Bionor Pharma Company Summary
7.7.2 Bionor Pharma Business Overview
7.7.3 Bionor Pharma HIV Antiretroviral Therapy Major Product Offerings
7.7.4 Bionor Pharma HIV Antiretroviral Therapy Revenue in Global Market (2018-2023)
7.7.5 Bionor Pharma Key News & Latest Developments
7.8 Vertex Pharmaceuticals
7.8.1 Vertex Pharmaceuticals Company Summary
7.8.2 Vertex Pharmaceuticals Business Overview
7.8.3 Vertex Pharmaceuticals HIV Antiretroviral Therapy Major Product Offerings
7.8.4 Vertex Pharmaceuticals HIV Antiretroviral Therapy Revenue in Global Market (2018-2023)
7.8.5 Vertex Pharmaceuticals Key News & Latest Developments
7.9 Merck
7.9.1 Merck Company Summary
7.9.2 Merck Business Overview
7.9.3 Merck HIV Antiretroviral Therapy Major Product Offerings
7.9.4 Merck HIV Antiretroviral Therapy Revenue in Global Market (2018-2023)
7.9.5 Merck Key News & Latest Developments
7.10 CIPLA
7.10.1 CIPLA Company Summary
7.10.2 CIPLA Business Overview
7.10.3 CIPLA HIV Antiretroviral Therapy Major Product Offerings
7.10.4 CIPLA HIV Antiretroviral Therapy Revenue in Global Market (2018-2023)
7.10.5 CIPLA Key News & Latest Developments
7.11 AbbVie
7.11.1 AbbVie Company Summary
7.11.2 AbbVie Business Overview
7.11.3 AbbVie HIV Antiretroviral Therapy Major Product Offerings
7.11.4 AbbVie HIV Antiretroviral Therapy Revenue in Global Market (2018-2023)
7.11.5 AbbVie Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. HIV Antiretroviral Therapy Market Opportunities & Trends in Global Market
Table 2. HIV Antiretroviral Therapy Market Drivers in Global Market
Table 3. HIV Antiretroviral Therapy Market Restraints in Global Market
Table 4. Key Players of HIV Antiretroviral Therapy in Global Market
Table 5. Top HIV Antiretroviral Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global HIV Antiretroviral Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global HIV Antiretroviral Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies HIV Antiretroviral Therapy Product Type
Table 9. List of Global Tier 1 HIV Antiretroviral Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HIV Antiretroviral Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global HIV Antiretroviral Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - HIV Antiretroviral Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - HIV Antiretroviral Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global HIV Antiretroviral Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - HIV Antiretroviral Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - HIV Antiretroviral Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global HIV Antiretroviral Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global HIV Antiretroviral Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global HIV Antiretroviral Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America HIV Antiretroviral Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe HIV Antiretroviral Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia HIV Antiretroviral Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America HIV Antiretroviral Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa HIV Antiretroviral Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Gilead Company Summary
Table 31. Gilead HIV Antiretroviral Therapy Product Offerings
Table 32. Gilead HIV Antiretroviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Gilead Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche HIV Antiretroviral Therapy Product Offerings
Table 36. Roche HIV Antiretroviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. ViiV Healthcare Company Summary
Table 39. ViiV Healthcare HIV Antiretroviral Therapy Product Offerings
Table 40. ViiV Healthcare HIV Antiretroviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. ViiV Healthcare Key News & Latest Developments
Table 42. Boehringer Ingelheim Company Summary
Table 43. Boehringer Ingelheim HIV Antiretroviral Therapy Product Offerings
Table 44. Boehringer Ingelheim HIV Antiretroviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Boehringer Ingelheim Key News & Latest Developments
Table 46. Johnson and Johnson Company Summary
Table 47. Johnson and Johnson HIV Antiretroviral Therapy Product Offerings
Table 48. Johnson and Johnson HIV Antiretroviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson and Johnson Key News & Latest Developments
Table 50. Mylan Company Summary
Table 51. Mylan HIV Antiretroviral Therapy Product Offerings
Table 52. Mylan HIV Antiretroviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Mylan Key News & Latest Developments
Table 54. Bionor Pharma Company Summary
Table 55. Bionor Pharma HIV Antiretroviral Therapy Product Offerings
Table 56. Bionor Pharma HIV Antiretroviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Bionor Pharma Key News & Latest Developments
Table 58. Vertex Pharmaceuticals Company Summary
Table 59. Vertex Pharmaceuticals HIV Antiretroviral Therapy Product Offerings
Table 60. Vertex Pharmaceuticals HIV Antiretroviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Vertex Pharmaceuticals Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck HIV Antiretroviral Therapy Product Offerings
Table 64. Merck HIV Antiretroviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. CIPLA Company Summary
Table 67. CIPLA HIV Antiretroviral Therapy Product Offerings
Table 68. CIPLA HIV Antiretroviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. CIPLA Key News & Latest Developments
Table 70. AbbVie Company Summary
Table 71. AbbVie HIV Antiretroviral Therapy Product Offerings
Table 72. AbbVie HIV Antiretroviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. AbbVie Key News & Latest Developments
List of Figures
Figure 1. HIV Antiretroviral Therapy Segment by Type in 2022
Figure 2. HIV Antiretroviral Therapy Segment by Application in 2022
Figure 3. Global HIV Antiretroviral Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global HIV Antiretroviral Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global HIV Antiretroviral Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by HIV Antiretroviral Therapy Revenue in 2022
Figure 8. By Type - Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global HIV Antiretroviral Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global HIV Antiretroviral Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
Figure 16. US HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
Figure 20. Germany HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
Figure 28. China HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE HIV Antiretroviral Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Gilead HIV Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche HIV Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. ViiV Healthcare HIV Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Boehringer Ingelheim HIV Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson and Johnson HIV Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Mylan HIV Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bionor Pharma HIV Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Vertex Pharmaceuticals HIV Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Merck HIV Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. CIPLA HIV Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. AbbVie HIV Antiretroviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
